跳至主要内容
临床试验/JPRN-UMIN000039266
JPRN-UMIN000039266已完成未知

A study on the effects of Jerusalem artichoke inulin intake on reducing visceral fat: A double-blind parallel group comparative study. - A study on the effects of Jerusalem artichoke inulin intake on reducing visceral fat: A double-blind parallel group comparative study.

imeQ RD inc.0 个研究点目标入组 20 人开始时间: 2020年1月27日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Those who are currently receiving some types of drug treatment, for example, treatment affecting obesity, hyperlipidemia, lipid metabolism, and harmonious intestinal action (except for the drugs that are taken as needed in those with complications or living with chronic diseases). 2. Those who are receiving nutrition therapy or physical therapy under a doctor's supervision. 3. Those who cannot stop taking health foods or supplements during the study period. 4. Those who cannot stop drinking alcohol the day before a test. 5. Those who have a current or a past medical history of severe diseases. 6. Those who have a current or a past medical history of drug or food allergy. 7. Those who have a current or a past medical history of drug or alcohol dependence. 8. Those who have metals implanted in the body due to surgery etc. 9. Those who have a cardiac pacemaker or an implantable medical device placed in the body. 10. Those who have claustrophobia. 11. Smokers. 12. Those who work night shifts. 13. Those who are currently pregnant or breastfeeding or those who want to become pregnant during the study period. 14. Those who are currently participating in another clinical trial or those who took a test product and completed another clinical trial in a month. 15. Those who were determined by the principal investigator to be an unsuitable subject for this study.

研究者

发起方
imeQ RD inc.

相似试验